Neutrophil elastase as a target in lung cancer

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Human neutrophil elastase (HNE) is implicated in chronic obstructive pulmonary diseases and non-small cell lung cancer progression.
• HNE exerts its effects intracellularly, at the cell surface, and extracellularly, influencing cancer cell invasiveness and angiogenesis.
• Proteolytic cascades involving HNE and matrix metalloproteinases (MMPs) are crucial in lung tumor invasion and metastasis.

Purpose of the Study:

• To review natural compounds and synthetic agents that antagonize HNE activity.
• To focus on natural substances with dual inhibitory capacity against HNE and MMPs, particularly MMP-2.
• To propose a synthetic strategy for developing potent dual HNE/MMP-2 inhibitors.

Main Methods:

• Literature review of compounds targeting HNE and MMPs.
• Synthesis and characterization of bifunctional inhibitors, such as LipoGalardin.
• Development of a novel synthetic scheme for dual inhibitors.

Main Results:

• Identification of various natural compounds and synthetic agents with HNE inhibitory activity.
• Demonstration of dual inhibitory capacity of certain natural substances (lipids, phenolics) against HNE and MMP-2.
• Successful synthesis of LipoGalardin, a bifunctional HNE/MMP inhibitor.

Conclusions:

• Natural compounds and synthetic agents hold potential as therapeutic agents for lung cancer.
• Dual inhibitors targeting HNE and MMPs offer a promising strategy for combating lung tumor invasion and metastasis.
• Further development of potent dual inhibitors like LipoGalardin could lead to novel lung cancer treatments.